Barclays’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$346K Buy
68,436
+37,114
+118% +$188K ﹤0.01% 3235
2025
Q1
$177K Sell
31,322
-2,995
-9% -$16.9K ﹤0.01% 3406
2024
Q4
$297K Buy
34,317
+5,629
+20% +$48.7K ﹤0.01% 3339
2024
Q3
$199K Buy
28,688
+21,971
+327% +$152K ﹤0.01% 3478
2024
Q2
$42K Buy
+6,717
New +$42K ﹤0.01% 3732